COL1A1 rs1107946: Genetics and Ligament Health
The genetic variant rs1107946 is a single-nucleotide polymorphism located in the promoter region of the COL1A1 gene, historically designated as -1997G/T. It influences the transcriptional activity of type I collagen, an essential structural component of connective tissues such as tendons, ligaments, and bone. In sports genomics, researchers have explored its statistical associations with musculoskeletal soft tissue injuries, including anterior cruciate ligament (ACL) tears and tendinopathies.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| GG | The homozygous common genotype carries two copies of the major G allele. In research cohorts, this genotype is frequently used as the baseline comparison group when assessing collagen expression and soft tissue injury susceptibility. It represents the typical structural baseline for connective tissue regulation. | Informational |
| GT | The heterozygous genotype carries one copy of the G allele and one copy of the minor T allele. Individuals with this genotype produce intermediate transcriptional dynamics in promoter reporter assays. Population studies suggest an intermediate association profile regarding ligament and tendon rupture risk. | Informational |
| TT | The homozygous minor genotype carries two copies of the regulatory T allele. In several candidate sports genomics studies, the T allele and TT genotype have been evaluated for reduced odds of acute ligament ruptures, though findings remain modest and statistically limited across broader independent cohorts. | Favorable |
What is rs1107946 and Where is It Located?
The single-nucleotide polymorphism rs1107946 is a genetic substitution located upstream in the 5-prime regulatory promoter region of the COL1A1 gene on human chromosome 17. In the sports medicine and bone literature, it is frequently referred to by its legacy promoter position as -1997G/T. Because it resides in a non-coding promoter sequence rather than within a protein-coding exon, it does not alter the primary amino acid sequence of the collagen peptide. Instead, nucleotide variations at this site can modify the binding affinity of specific transcription factors, modulating the basal rate at which the COL1A1 gene is transcribed into messenger RNA.
The Biological Function of COL1A1 and Collagen Type I
The COL1A1 gene encodes the pro-alpha-1 chain of type I collagen, which is the most abundant structural protein in the human body. Two alpha-1 chains typically assemble with one alpha-2 chain (encoded by COL1A2) to form a strong, triple-helical heterotrimer. Type I collagen fibrils provide critical tensile strength and load-bearing resilience to tendons, ligaments, joint capsules, skin, and bones. Balanced expression of collagen chains is necessary for normal fibril diameter, tissue stiffness, and biomechanical integrity. Variations that alter promoter efficiency may subtly shift collagen production, altering how connective tissues adapt to chronic mechanical stress or acute high-energy impacts.
Research Associations with Soft Tissue and Ligament Injuries
Multiple candidate-gene association studies have evaluated rs1107946 alongside adjacent COL1A1 polymorphisms, such as the functional Sp1 binding site variant rs1800012, to assess predisposition to soft tissue injuries. Researchers have observed statistical associations between rs1107946 alleles—either independently or as part of specific multi-marker promoter haplotypes—and altered susceptibility to anterior cruciate ligament (ACL) ruptures, Achilles tendon injuries, and shoulder instability. Some investigations report that carrying specific promoter alleles confers modest protective effects against acute ligament ruptures. However, the overall strength of scientific evidence remains classified as limited due to small candidate-gene cohort sizes, lack of broad genome-wide significance, and inconsistent findings across diverse populations.
Ancestry and Population Frequencies
The distribution of the alleles at rs1107946 varies meaningfully across global populations. In individuals of European descent, the minor T allele typically occurs at an estimated frequency between 18% and 22%, with the major G allele representing the majority of observed chromosomes. Global public databases like gnomAD demonstrate that allele frequencies can fluctuate substantially among other ancestries, such as African, East Asian, and admixed populations. Because linkage disequilibrium patterns between rs1107946 and adjacent regulatory sites differ substantially between ancestral backgrounds, any potential physiological impact of the variant may be context-dependent and ancestry-specific.
Translating Genetic Results: Possibilities and Limitations
It is essential to understand that rs1107946 is not a diagnostic marker and cannot predict whether an individual will experience a tendon injury or ligament tear. Musculoskeletal injuries are complex, multifactorial events determined by environmental and physical factors including training volume, neuromuscular biomechanics, fatigue, hormonal influences, playing surface, and footwear. A specific genotype at rs1107946 accounts for only a minor fraction of overall biological variation in tissue resilience. Athletes and active individuals should not use this genetic marker to alter injury rehabilitation or clinical treatments, but instead rely on evidence-based conditioning, balanced strength training, and appropriate rest protocols.
How common is this variant?
The minor T allele frequency is approximately 0.18 to 0.22 in European populations, while the ancestral G allele represents the predominant allele globally across reference populations in gnomAD.
Frequently asked questions
Can testing rs1107946 determine if I will tear my ACL?
No, this genetic test cannot diagnose or predict whether you will experience an ACL tear. Ligament ruptures depend primarily on biomechanical forces, physical conditioning, sports participation, and environmental circumstances. The variant is merely a statistical association in population-level studies.
Does having a specific rs1107946 genotype mean I need collagen supplements?
No direct clinical evidence supports targeted collagen supplementation based on your rs1107946 genotype. Collagen synthesis relies on balanced nutrition and appropriate mechanical stimulus rather than genotype-guided supplementation. Consult a registered dietitian or physician before starting any dietary supplement regimen.
What is the difference between rs1107946 and -1997G/T?
They refer to the exact same genetic variation. The code rs1107946 is the standardized dbSNP reference identifier, whereas -1997G/T is a traditional designation denoting the variant's position 1,997 base pairs upstream of the COL1A1 transcription start site.
Should athletes adjust their training based on this variant?
No, athletes should not modify their training solely based on genetic results from rs1107946. Established neuromuscular warm-up programs, proper conditioning, and adequate recovery periods provide proven injury reduction benefits regardless of individual genetic variations.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1107946?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29